Line Plot from Scientific Research

The proportion of patients meeting the primary endpoint of collecting to goal within two apheresis days and the key secondary endpoint of collecting to goal in one apheresis day are shown, along with collection rates after three and four apheresis procedures. No patients in the motixafortide + G-CSF arm underwent a fourth apheresis on protocol. The primary endpoint and prespecified secondary efficacy endpoint were analyzed using the CMH test and are presented as OR with two-sided 95% CIs and P values.

DOI